Big Pharma playing system to secure lucrative funding deals in Central Europe. New research from an international group of health policy experts led by the University of Bath (U.K.) reports a mixed picture of transparency in public decision making around new medicine approvals in Poland, one of Europe’s largest pharmaceutical markets. Despite a troubled relationship with the European…
